Role of HIF-1α and CASPASE-3 in Cystogenesis of Odontogenic Cysts and Tumors

Overview

Journal Clin Oral Investig

Specialty Dentistry

Date 2017 Feb 27

PMID 28238093

Citations 13

Authors

Natacha M M da Costa

Adriane S de Siqueira

Andre L R Ribeiro

Maria S da Silva Kataoka

Ruy G Jaeger

Sergio M de Alves-Junior

Andrew M Smith

Joao de Jesus Viana Pinheiro

Affiliations

Soon will be listed here.

Abstract

Objectives: Odontogenic cysts and tumors are the most relevant lesions that affect the gnathic bones. These lesions have in common the formation of cystic areas and this common feature may suggest involvement of similar mechanisms. The hypoxia inducible factor 1 alpha (HIF-1α), a responsive protein to hypoxia and caspase-3, an irreversible apoptosis marker, may contribute to cyst formation. Thus, this study aimed to investigate the immunoexpression of these proteins in odontogenic cysts and tumors.

Material And Methods: Twenty cases of ameloblastoma, keratocystic odontogenic tumor (KOT) (n = 20), radicular cyst (RC) (n = 18), dentigerous cyst (DC) (n = 11), calcifying cystic odontogenic tumor (n = 8), and dental follicle (DF) (n = 10) were used to investigate HIF-1α and caspase-3 expression in sequential serial cuts by immunohistochemistry.

Results: HIF-1α was overexpressed in RC, DC, and ameloblastoma when compared with DF. The basal and sometimes the lower suprabasal layer showed no or very low expression in DC, KOT, and ameloblastoma, the last also showing strong expression in solid epithelial areas and initial cystic formation regions. Caspase-3 was found to be overexpressed in all lesions, with the highest expression in odontogenic cysts compared to tumors. HIF-1α and caspase-3 were localized in similar areas of the same lesions, especially in the epithelium surrounding cystic formations.

Conclusions: This study showed distinct immunoexpression of HIF-1α and caspase-3 in odontogenic cyst and tumors, with higher expression observed in odontogenic cysts.

Clinical Relevance: These findings suggest a possible correlation between hypoxia, apoptosis, and cystogenesis, leading to understand the mechanisms responsible to cystic formation in odontogenic lesions.

Citing Articles

Inspiring Tactics with the Improvement of Mitophagy and Redox Balance for the Development of Innovative Treatment against Polycystic Kidney Disease.

Nakashima M, Suga N, Ikeda Y, Yoshikawa S, Matsuda S Biomolecules. 2024; 14(2).

PMID: 38397444 PMC: 10886467. DOI: 10.3390/biom14020207.

Comprehensive insights into the understanding of hypoxia in ameloblastoma.

Bologna-Molina R, Schuch L, Niklander S Histol Histopathol. 2024; 39(8):983-989.

PMID: 38362601 DOI: 10.14670/HH-18-718.

Prognostic value of the expression and localization of cell proliferation and apoptosis markers in unicystic ameloblastomas.

Costa R, Balbinot K, da Silveira G, da Silva Kataoka M, de Menezes S, Freitas V Sci Rep. 2024; 14(1):3856.

PMID: 38360984 PMC: 10869795. DOI: 10.1038/s41598-024-54132-7.

Role of HIF-1α in Ameloblastoma: A Systematic Review.

Jain A, Sharma P, Sivakumar N, Devi P, Gupta S, Chandra S Indian J Otolaryngol Head Neck Surg. 2023; 75(4):3136-3145.

PMID: 37974737 PMC: 10646133. DOI: 10.1007/s12070-023-03928-6.

Expression of stem cell markers SALL4, LIN28A, and KLF4 in ameloblastoma.

de Albuquerque Dias R, Balbinot K, da Silva Kataoka M, de Melo Alves Junior S, de Jesus Viana Pinheiro J Diagn Pathol. 2023; 18(1):92.

PMID: 37559082 PMC: 10413759. DOI: 10.1186/s13000-023-01379-9.

References

Ward J, Magar V, Franks S, Landini G . A mathematical model of the dynamics of odontogenic cyst growth. Anal Quant Cytol Histol. 2004; 26(1):39-46. View

Ribeiro A, da Costa N, de Siqueira A, Brasil da Silva W, da Silva Kataoka M, Jaeger R . Keratocystic odontogenic tumor overexpresses invadopodia-related proteins, suggesting invadopodia formation. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016; 122(4):500-8. DOI: 10.1016/j.oooo.2016.06.004. View

Seifi S, Shafigh E, Allaie A . Quantitative and qualitative analysis of argyrophilic nuclear organizer regions in follicular cyst, keratocystic odontogenic tumor and ameloblastoma. J Cancer Res Ther. 2011; 7(3):280-5. DOI: 10.4103/0973-1482.87017. View

Chen D, Li M, Luo J, Gu W . Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function. J Biol Chem. 2003; 278(16):13595-8. DOI: 10.1074/jbc.C200694200. View

Moritz W, Meier F, Stroka D, Giuliani M, Kugelmeier P, Nett P . Apoptosis in hypoxic human pancreatic islets correlates with HIF-1alpha expression. FASEB J. 2002; 16(7):745-7. DOI: 10.1096/fj.01-0403fje. View

van Hoecke M, Prigent-Tessier A, Garnier P, Bertrand N, Filomenko R, Bettaieb A . Evidence of HIF-1 functional binding activity to caspase-3 promoter after photothrombotic cerebral ischemia. Mol Cell Neurosci. 2006; 34(1):40-7. DOI: 10.1016/j.mcn.2006.09.009. View

Cho S, Teng I, Zhang M, Yin T, Jung Y, Zhang J . Hypoxia-inducible factor 1 alpha is regulated by RBM38, a RNA-binding protein and a p53 family target, via mRNA translation. Oncotarget. 2015; 6(1):305-16. PMC: 4381596. DOI: 10.18632/oncotarget.2786. View

Belibi F, Zafar I, Ravichandran K, Segvic A, Jani A, Ljubanovic D . Hypoxia-inducible factor-1α (HIF-1α) and autophagy in polycystic kidney disease (PKD). Am J Physiol Renal Physiol. 2011; 300(5):F1235-43. PMC: 3094047. DOI: 10.1152/ajprenal.00348.2010. View

Pinheiro J, Freitas V, Moretti A, Jorge A, Jaeger R . Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity. Histopathology. 2004; 45(1):65-72. DOI: 10.1111/j.1365-2559.2004.01902.x. View

10.

Wang G, Semenza G . Purification and characterization of hypoxia-inducible factor 1. J Biol Chem. 1995; 270(3):1230-7. DOI: 10.1074/jbc.270.3.1230. View

11.

Kohl R, Zhou J, Brune B . Reactive oxygen species attenuate nitric-oxide-mediated hypoxia-inducible factor-1alpha stabilization. Free Radic Biol Med. 2006; 40(8):1430-42. DOI: 10.1016/j.freeradbiomed.2005.12.012. View

12.

Casely-Hayford M, Nicholas S, Sumbayev V . Azinomycin epoxide induces activation of apoptosis signal-regulating kinase 1 (ASK1) and caspase 3 in a HIF-1alpha-independent manner in human leukaemia myeloid macrophages. Eur J Pharmacol. 2008; 602(2-3):262-7. DOI: 10.1016/j.ejphar.2008.12.001. View

13.

Maxwell P . HIF-1: an oxygen response system with special relevance to the kidney. J Am Soc Nephrol. 2003; 14(11):2712-22. DOI: 10.1097/01.asn.0000092792.97122.e0. View

14.

Lee J, Bae S, Jeong J, Kim S, Kim K . Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med. 2004; 36(1):1-12. DOI: 10.1038/emm.2004.1. View

15.

Metgud R, Gupta K . Expression of cell cycle and apoptosis-related proteins in ameloblastoma and keratocystic odontogenic tumor. Ann Diagn Pathol. 2013; 17(6):518-21. DOI: 10.1016/j.anndiagpath.2013.06.006. View

16.

Ribeiro A, Nobre R, Alves-Junior S, Kataoka M, Barroso R, Jaeger R . Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and growth factors regulate the aggressiveness and proliferative activity of keratocystic odontogenic tumors. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012; 114(4):487-96. DOI: 10.1016/j.oooo.2012.06.011. View

17.

Kieda C, Greferath R, Crola Da Silva C, Fylaktakidou K, Lehn J, Nicolau C . Suppression of hypoxia-induced HIF-1alpha and of angiogenesis in endothelial cells by myo-inositol trispyrophosphate-treated erythrocytes. Proc Natl Acad Sci U S A. 2006; 103(42):15576-81. PMC: 1622864. DOI: 10.1073/pnas.0607109103. View

18.

Reichart P, Philipsen H, Sonner S . Ameloblastoma: biological profile of 3677 cases. Eur J Cancer B Oral Oncol. 1995; 31B(2):86-99. DOI: 10.1016/0964-1955(94)00037-5. View

19.

Hammond E, Asselin M, Forster D, OConnor J, Senra J, Williams K . The meaning, measurement and modification of hypoxia in the laboratory and the clinic. Clin Oncol (R Coll Radiol). 2014; 26(5):277-88. DOI: 10.1016/j.clon.2014.02.002. View

20.

Greijer A, van der Wall E . The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol. 2004; 57(10):1009-14. PMC: 1770458. DOI: 10.1136/jcp.2003.015032. View